Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
- Alternative title
-
Molekulare Mechanismen der Dysregulation des Zytoskeletts in der Spinalen Muskelatrophie (SMA)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (who)
-
Stiftung Tierärztliche Hochschule Hannover
- (when)
-
2023
- Creator
- Contributor
- URN
-
urn:nbn:de:gbv:95-119041
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schüning, Tobias
- Claus, Peter
- Ponimaskin, Evgeni
- Tipold, Andrea
- Stiftung Tierärztliche Hochschule Hannover
Time of origin
- 2023
Other Objects (12)
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Pattern of pareses in 5q-spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen
Dynamics and regulation of the actin cytoskeleton in the motoneuron disease Spinal Muscular Atrophy (SMA)
T-plastin, a cytoskeletal protein with important function in axonal growth, acts as a modifier of spinal muscular atrophy
T-plastin, a cytoskeletal protein with important function in axonal growth, acts as a modifier of spinal muscular atrophy
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Costs of illness of spinal muscular atrophy: a systematic review
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Identification and characterization of spinal muscular atrophy (SMA) modifiers - insight from cellular and vertebrate disease models
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Pattern of pareses in 5q-spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen
Dynamics and regulation of the actin cytoskeleton in the motoneuron disease Spinal Muscular Atrophy (SMA)
T-plastin, a cytoskeletal protein with important function in axonal growth, acts as a modifier of spinal muscular atrophy
T-plastin, a cytoskeletal protein with important function in axonal growth, acts as a modifier of spinal muscular atrophy
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Costs of illness of spinal muscular atrophy: a systematic review
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Identification and characterization of spinal muscular atrophy (SMA) modifiers - insight from cellular and vertebrate disease models
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Pattern of pareses in 5q-spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen
Dynamics and regulation of the actin cytoskeleton in the motoneuron disease Spinal Muscular Atrophy (SMA)
T-plastin, a cytoskeletal protein with important function in axonal growth, acts as a modifier of spinal muscular atrophy
T-plastin, a cytoskeletal protein with important function in axonal growth, acts as a modifier of spinal muscular atrophy
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Costs of illness of spinal muscular atrophy: a systematic review
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy